Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-05-09

FDA Approved: TACLONEX — Original Application (LEO Pharma Inc.)

View source ↗

Summary

FDA approved Taclonex, a topical combination of calcipotriol and betamethasone dipropionate, under Original Application by LEO Pharma Inc. for treatment of plaq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TACLONEX (calcipotriol and betamethone dipropionate)

Snippet

ORIG AP for TACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)